Cronos Group Inc. (TSX:CRON)
Canada
· Delayed Price · Currency is CAD | Market Cap | 1.06B |
| Revenue (ttm) | 179.08M |
| Net Income (ttm) | 71.07M |
| Shares Out | 382.53M |
| EPS (ttm) | 0.18 |
| PE Ratio | 15.63 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 168,459 |
| Average Volume | 131,363 |
| Open | 2.780 |
| Previous Close | 2.760 |
| Day's Range | 2.765 - 2.870 |
| 52-Week Range | 2.270 - 4.280 |
| Beta | 1.53 |
| RSI | 66.52 |
| Earnings Date | May 13, 2025 |
About Cronos Group
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada. [Read more]
News
This Week In Cannabis: Earnings Divide The Market As DEA, Brands And Bills Move Forward
The cannabis industry just wrapped one of the busiest earnings weeks of the quarter, with more than ten companies reporting financials—including Curaleaf, GTI, Trulieve, Verano, Cronos Group and IIPR....
Top 3 Marijuana Stocks For Better Investing 2025
The current state of marijuana stocks could keep some people discouraged. With no federal reform or bills to ease tax burdens and improve banking access, this has led to a downtrend. A volatile wave o...
Marijuana Stock Movers For May 8, 2025
GAINERS: CNBX Pharmaceuticals (OTC: CNBX) shares closed up 15.00% at $0.00 Cronos Group (NASDAQ: CRON) shares closed up 9.19% at $2.00 SOL Global Investments (OTC: SOLCF) shares closed up 9.15% at ...
Cronos Group Inc. (CRON) Q1 2025 Earnings Call Transcript
Cronos Stock Surges On Q1 Earnings Beat, 'Strong' Demand For Flower Products: '2025 Is Shaping Up To Be A Transformative Year'
Cronos Group Inc (NASDAQ: CRON) reported first-quarter financial results ahead of the market open Thursday. Here’s a look at the key highlights from the cannabis company’s report . Q1 Revenue: Cronos...
Cannabis Earnings Show Market Split: US Plant-Touching Stocks Drop, IIPR And Cronos Up
Between Wednesday afternoon and Thursday morning, a slate of major cannabis companies reported their first quarter 2025 financial results. These included Green Thumb Industries (CSE: GTII) (OTCQX: GT...
Cronos Group Reports 2025 First Quarter Results
Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis
3 Marijuana Stocks For The Long Term Investing
Marijuana stocks hold lots of potential for home-run investments in the future. In 2018, most pot stocks saw their first wave of the green rush. Yet over the last several years, this has not been the ...
Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:0...
3 Canadian Marijuana Stocks That Could See Big Future Gains
When it comes to finding marijuana stocks to buy a happy medium or silver lining at this time is tough to do. Not becuase the low share prices from some of the top-performing companies dont look appet...
2 Canadian Marijuana Stocks For Your Upcoming Watchlist
Marijuana stocks are torn between two ferns, and this has created a volatile frenzy in the sector. It could be that people feel the cannabis sector will eventually take the behavior of other sectors w...
3 Canadian Marijuana Stocks For Long-Term Investing
Marijuana stock investors are torn between several paths. With how volatile the space is, much of the sector is trading at low price points. It is almost safe to say that more than half of those who h...
Top Canadian Cannabis Stocks to Watch in April 2025
Top Canadian cannabis stocks are attracting attention this week as investors seek opportunities in a rapidly evolving industry. Companies like Cronos Group, SNDL Inc., and Aurora Cannabis continue str...
Marijuana Stock Movers For March 24, 2025
GAINERS: Affinor Growers (OTC: RSSFF) shares closed up 19.75% at $0.05 Blueberries Medical (OTC: BBRRF) shares closed up 16.25% at $0.01 CNBX Pharmaceuticals (OTC: CNBX) shares closed up 11.98% at ...
Cronos Stock: Win Big Or Lose All
I maintain a 'strong buy' rating for Cronos, despite regulatory headwinds, due to its strong fundamentals and potential for multibagger returns. Cronos has shown positive progress with a robust cash b...
3 Canadian Marijuana Stocks To Watch For Future Gains 2025
Marijuana stocks have been facing a downward trend in the market for some time. A big reason is regulatory uncertainty and reform issues. Legislative changes, particularly in major markets like the U....
Cronos Appoints Anna Shlimak as Chief Financial Officer
TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Anna ...
Cronos Group Inc. (CRON) 37th Annual Roth Conference (Transcript)
Cronos Group Inc. to Speak at the 37th Annual Roth Conference
TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Ch...
Cronos Reports Improved Q4-2024 Financials With Revenues From GrowCo
Cronos reported 27% increase in revenues YOY for Q4-2024. The company is now reporting revenues from its 50% ownership of GrowCo. The company reported increasing profits and free cash flow for the qua...
Top Marijuana Stocks To Know In Today's Stock Market 2025
As the cannabis industry continues to grow, more companies are expanding their product lines beyond traditional flower sales. This includes edibles, oils, and wellness products, attracting a broader c...
Cronos Q4 Sales Jump 27% On Higher Cannabis Flower And Extract Sales, Reports Improved Profitability
On Thursday, Cronos Group Inc (NASDAQ: CRON) reported fourth-quarter sales of $30.3 million, up from $23.92 million, missing the consensus of $34.95 million . The increase year-over-year was primaril...
Cronos Q4 Sales Jump 27% On Higher Cannabis Flower And Extract Sales, Reports Improved Profitability
On Thursday, Cronos Group Inc CRON reported fourth-quarter sales of $30.3 million, up from $23.92 million, missing the consensus of $34.95 million.
Cronos Group (CRON) Q4 2024 Earnings Call Transcript
CRON earnings call for the period ending December 31, 2024.